GeneDx Holdings Corp. is 1.4x more valuable than InnovAge Holding Corp. by market capitalization ($1.61 B vs $1.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | WGS | INNV |
|---|---|---|
| Market cap | $1.61 B | $1.13 B |
| US-listed rank | #2258 | #2549 |
| Revenue (latest FY) | $427.54M | $853.70M |
| Net income (latest FY) | -$21.00M | -$30.31M |
| Net margin | -4.9% | -3.6% |
| SEC filings | 748 | 227 |
GeneDx Holdings Corp. is 1.4x more valuable than InnovAge Holding Corp. by market capitalization ($1.61 B vs $1.13 B).
In their latest fiscal years, GeneDx Holdings Corp. reported $427.54M in revenue while InnovAge Holding Corp. reported $853.70M.
Full pages: GeneDx Holdings Corp. and InnovAge Holding Corp., or browse the full rankings.